Lemtrada: new treatment for relapsing remitting MSTwo treatment courses reduce relapse risk and disability accumulation. Updated Canadian statement on the use of herpes zoster vaccineNew statement provides clarity on several controversial issues. Alzheimer risk starts early Aubagio: new oral therapy for MS Drug approved for use as a monotherapy to reduce the frequency of clinical exacerbations, delay accumulation of physical disability. Chewing gum causing migraines? Israeli study suggests gum may be causing headaches in teens. Drug hits Parkinson’s psychosis Two drugs better than one in secondary stroke prevention Researchers recommend dual antiplatelet therapy over monotherapy CADTH Corner: Preventing stroke in patients with atrial fibrillation—what about ASA? Canadian study sounds ‘death knell’ for Zamboni theory of MS But decision to continue Canadian treatment trial draws fire —and praise Never miss a subarachnoid hemorrhage Study suggests headache decision aid has perfect sensitivity First Previous 38 39 40 41 42 Next Last
